Yorkshire health firm completes "major" multi-million pound facility expansion

A Yorkshire health company has announced that it has completed a “major” expansion of its test manufacturing facility.

Abingdon Health has expanded its York Biotech facility, meaning that the company now has the capacity to manufacture millions of rapid tests a month.

The expansion came in response to the Covid-19 pandemic, as the company developed antibody tests for the virus.

This is Abingdon Health’s third expansion at York Biotech Campus in the last year, as well as the addition of a manufacturing site in Doncaster, with an investment of £5.5m across the year.

Oliver Gardner, COO at Abingdon Health, commented: “The pandemic has raised awareness for the need for rapid testing across industries, not only for Covid-19.

“The demand for rapid tests will continue to grow across healthcare and areas such as crop production, animal health and farming.

“With the market set to exceed £9bn in the near future, we are well positioned to keep pace with demand.

“The new space at our York headquarters is a vital element in becoming one of the world’s leading rapid diagnostic manufacturers, helping more people every day to receive quick and accurate results.”

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →